Generic Name and Formulations:
Lidocaine 5%; adhesive patch.
Indications for LIDODERM:
Apply to intact skin, covering most painful area. To adjust dose, cut patches before removing release liner. Remove if irritation or burning occurs; do not reapply until irritation subsides. May apply up to 3 patches at once for up to 12hrs of a 24-hour period. Hepatic impairment or debilitated: use smaller treatment areas.
Do not apply to broken or inflamed skin. Avoid eyes, mucous membranes, longer duration of application, and application of more than 3 patches. Do not ingest; may be toxic to children and pets. Hepatic disease. Small patients. Pregnancy (Cat.B). Labor & delivery. Nursing mothers.
Toxicity may be potentiated by Class I antiarrhythmics (e.g., tocainide, mexiletine). Additive effects with other local anesthetics.
Local effects (e.g., erythema, edema), allergic reactions (e.g., urticaria, angioedema, bronchospasm).
Patches (10cm x 14cm)—30
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Electroacupuncture May Help Reduce Opioid Use in Chronic Musculoskeletal Pain
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics